# Alignment Healthcare Inc. (ALHC) fundamentals

Data as of 2026-11-04. NASDAQ, United States. Sector: Healthcare / Health Care Providers. Price $7.39, market value $1.5 billion.

## Valuation
- **P/E (trailing): 52.8×**. Alignment Healthcare Inc. trades at 52.8× trailing earnings. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 13.3×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.13**. A PEG of 0.13 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 0.3×**. Each dollar of revenue is priced at 0.3×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 5.6×**. The shares trade at 5.6× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **EV / EBITDA: 17.2×**. Enterprise value is 17.2× operating earnings before depreciation, the multiple that ignores how the company is financed.
- **Free-cash-flow yield: 5.0%** (5-yr avg -1.7%). Free cash flow equals 5.0% of the market value, above its five-year average of -1.7%, so the shares are cheaper on cash than they have usually been.
- **Earnings yield: 1.9%**. The inverse of the P/E: 1.9% of the price is earned each year.

## Profitability
- **Operating margin: 0.9%**. 0.9% of revenue is left after running the business, which leaves little cushion in a downturn.
- **Net margin: -0.0%**. The company reported a net loss over the last twelve months.
- **Return on equity: -0.4%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -46.9%**. Return on all capital, debt included, is -46.9%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: 2.7%**. Each dollar of assets produces 2.7% of profit.

## Growth
- **Revenue growth (1 yr): 46.1%** (3-yr 40.2%/yr, 5-yr 32.8%/yr). Revenue grew 46.1% over the last year, against 32.8% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 100.0%**. Earnings per share rose 100.0%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 1.80**. Debt is 1.80 times equity, a leveraged balance sheet that needs steady cash flow to service.
- **Net debt / EBITDA: net cash**. Alignment Healthcare Inc. holds more cash than debt.
- **Current ratio: 1.71** (quick 1.71). Current assets cover the next year's liabilities 1.71 times.
- **Altman Z-score: 5.48**. A Z-score of 5.48 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Alignment Healthcare Inc. does not currently pay a dividend.

## Analyst view
- **Analyst consensus: buy** (12 analysts). 12 analysts cover Alignment Healthcare Inc.; the consensus is buy, with an average price target of $11.13 (+51% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -58.5%** (YTD -64.6%, 3-mo -51.9%). The shares are down 58.5% over twelve months including dividends.
- **From 52-week high: -70.6%** (23.0% above the low). Trading 71% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 29**. An RSI of 29 is oversold; bounces are common, but oversold can stay oversold in a real decline.
- **Beta (1 yr): 0.51** (volatility 70%). Beta of 0.51 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=ALHC · Page: https://foliofundamentals.com/stocks/alhc

Not investment advice.